Handelsbanken Fonder’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Sell
42,900
-14,400
-25% -$310K ﹤0.01% 1038
2026
Q1
$657K Buy
57,300
+16,900
+42% +$238K ﹤0.01% 1216
2025
Q4
$581K Buy
40,400
+2,000
+5% +$34.6K ﹤0.01% 1256
2025
Q3
$727K Buy
38,400
+5,600
+17% +$92.3K ﹤0.01% 1135
2025
Q2
$703K Buy
32,800
+3,000
+10% +$44.6K ﹤0.01% 1108
2025
Q1
$391K Hold
29,800
﹤0.01% 1325
2024
Q4
$401K Buy
29,800
+17,800
+148% +$287K ﹤0.01% 1376
2024
Q3
$255K Hold
12,000
﹤0.01% 1454
2024
Q2
$190K Hold
12,000
﹤0.01% 1490
2024
Q1
$178K Hold
12,000
﹤0.01% 1526
2023
Q4
$110K Buy
+12,000
New +$82.8K ﹤0.01% 1548

Other funds holding OSCR

Handelsbanken Fonder's OSCR Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Oscar Health (OSCR) stake by 25% in Q2 2026, selling an estimated $310K and leaving 42,900 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Handelsbanken Fonder first reported a position in OSCR in Q4 2023 and has held it in 11 quarters since. 26 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Handelsbanken Fonder held 42,900 shares of Oscar Health worth $1.22M as of Q2 2026.
  • Handelsbanken Fonder sold 14,400 Oscar Health shares in Q2 2026, an estimated $310K.
  • Oscar Health made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1038 holding.
  • Handelsbanken Fonder first reported a position in Oscar Health in Q4 2023 and has held it in 11 quarters since.
  • 26 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.